Flunitrazolam Blotters – 0.25mg

A. Introduction

Flunitrazolam Blotters 0.25mg are premium laboratory-grade research blotters containing triazolobenzodiazepine analog, designed for scientific institutions and analytical laboratories investigating designer benzodiazepine standards. This high-purity microdose blotter format provides researchers with consistent 0.25mg units for ultra-trace method validation, forensic screening, and reference material preparation in controlled settings.

B. Scientific Overview

Flunitrazolam belongs to the triazolobenzodiazepine class structurally related to flunitrazepam, characterized by its fused triazole-benzodiazepine scaffold with difluoro substitution suitable for analytical profiling. In research contexts, it functions as an analytical reference for studying chromatographic behavior, mass spectrometry fragmentation patterns, and spectroscopic signatures of high-potency benzodiazepine analogs.

Laboratory investigations focus exclusively on its physicochemical properties including sub-microgram solubility, thermal stability, and quantitative recovery characteristics under LC-MS/MS conditions, without reference to biological interactions.

C. Product Specifications

• Form: Perforated blotter paper squares containing 0.25mg flunitrazolam per unit for precise lab handling

• Label per unit: 0.25mg analytical portions (resealable packaging)

• Synonym: 3-(2-fluorophenyl)-6-fluoro-1-methyl-8-nitro-4H-triazolo[4,3-a]benzodiazepine

• CAS Number: 2243815-18-9

• Molecular Formula: C₁₇H₁₂F₂N₄O₂

• Molecular Weight: 354.30 g/mol

• Purity: ≥98% (HPLC, typical batch purity)

• Storage Conditions: -20°C freezer, desiccated, protected from light/moisture/air for maximum stability

D. Laboratory Use Context

Flunitrazolam Blotters 0.25mg are designated solely for in-vitro analytical research, including ultra-trace reference standard preparation, LC-HRMS method validation at pg/mL concentrations, forensic toxicology screening for designer benzodiazepines, and impurity profiling in complex matrices.

Researchers apply them in controlled environments for quantitative analysis at forensic limits of detection, positive ESI ionization studies ([M+H]+), and stability assessment via UHPLC-QTOF protocols. The blotter format facilitates reproducible sub-microgram transfers essential for method LOQ determination.

E. Quality & Testing

Every batch receives comprehensive quality control:

• Certificate of Analysis (COA) with HPLC, LC-MS/MS, NMR identity confirmation and blotter uniformity testing

• Full batch traceability from synthesis through blotter impregnation and verification

• Third-party ISO 17025 accredited laboratory testing for content uniformity (<3% RSD), homogeneity, and residual solvents

• Manufactured under controlled conditions ensuring consistent microdose deposition and long-term stability

F. Shipping & Handling

Discreet worldwide shipping to verified research laboratories via secure, temperature-controlled carriers meeting IATA/DOT standards for Schedule I research chemicals. Specialized low-moisture packaging with desiccant protection and full import documentation provided. Tracking included; buyers confirm jurisdictional compliance prior to purchase.

G. Compliance Disclaimer

For Research Use Only. Not for human consumption.
This product constitutes a controlled laboratory reagent supplied strictly for analytical research purposes. Not approved for human, veterinary, diagnostic, or therapeutic applications. No statements imply biological activity beyond controlled in-vitro analytical contexts.

Qualified researchers and institutions assume complete responsibility under local, federal, and international regulations. Seller disclaims all liability for non-research applications. Consult material safety data sheets and institutional handling protocols before use.